Edgar Filing: FLEXIBLE SOLUTIONS INTERNATIONAL INC

SCHEDULE 14A

SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

Filed by the Registrant [X]

Filed by Party other than the Registrant []

Check the appropriate box:

[] Preliminary Proxy Statement
[] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
(2))
[X] Definitive Proxy Statement
[] Definitive Additional Materials
[] Soliciting Material Pursuant to ss.240.14a-11(c) or ss.240.14a-12

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
(Name of Registrant as Specified In Its Charter)

William T. Hart - Attorney for Registrant
-------------------------------------------
(Name of Person(s) Filing Proxy Statement)

Payment of Filing Fee (Check the appropriate box):

[ ] $500 per each party to the controversy pursuant to Exchange Act Rule 14a-6
(i)(3)

[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

1) Title of each class of securities to which transaction applies:

----------------------------------------------------------------

2) Aggregate number of securities to which transaction applies:

----------------------------------------------------------------

3) Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0-11:

----------------------------------------------------------------

Flexible Solutions International, Inc.
615 Discovery St.
Victoria, BC
Canada V8T 5G4

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD AUGUST 29, 2013

To the Shareholders:

Notice is hereby given that the annual meeting of the shareholders of
Flexible Solutions International, Inc. ("Flexible Solutions") will be held at
the offices of the Company, located at 615 Discovery St., Victoria, BC V8T 5G4
on August 29, 2013, at 6:00 p.m. Pacific Time, for the following purposes:

(1) to elect the directors who shall constitute the Company's Board of
Directors for the ensuing year;

(2) to ratify an option granted to John Bientjes which would allow Mr.
Bientjes to purchase 5,000 shares of the Company's common stock at a price of
$1.21 per share at any time after December 31, 2013 and on or before December
31, 2017;

(3) to ratify an option granted to Dale Friend which would allow Ms. Friend
to purchase 5,000 shares of the Company's common stock at a price of $1.21 per
share at any time after December 31, 2013 and on or before December 31, 2017;

(4) to ratify an option granted to Robert Helina which would allow Mr.
Helina to purchase 5,000 shares of the Company's common stock at a price of
$1.21 per share at any time after December 31, 2013 and on or before December
31, 2017;

(5) to ratify an option granted to Dr. Thomas Fyles which would allow Dr.
Fyles to purchase 5,000 shares of the Company's common stock at a price of $1.21
per share at any time after December 31, 2013 and on or before December 31,
2017;

(6) to approve on an advisory basis, compensation of the Company's
executive officers;

(7) to ratify appointment of Meyers, Norris, Penny, LLP as the Company's
independent registered public accounting firm for the fiscal year ending
December 31, 2012; and

to transact such other business as may properly come before the meeting.

July 12, 2013 is the record date for the determination of shareholders
entitled to notice of and to vote at such meeting. Shareholders are entitled to
one vote for each share held. As of July 12, 2013 there were 13,169,991 issued
and outstanding shares of the Company's common stock.

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

July 12, 2013 ____________________________________
Daniel O'Brien
President

PLEASE INDICATE YOUR VOTING INSTRUCTIONS ON THE ATTACHED PROXY CARD,
AND SIGN, DATE AND RETURN THE PROXY CARD
TO SAVE THE COST OF FURTHER SOLICITATION,
PLEASE VOTE PROMPTLY

FLEXIBLE SOLUTIONS INTERNATIONAL, INC.

615 Discovery St.
Victoria, BC
Canada V8T 5G4
(250) 477-9969

PROXY STATEMENT

The accompanying proxy is solicited by the Company's directors for voting
at the annual meeting of shareholders to be held on August 29, 2013, at 6:00
p.m. Pacific Time, and at any and all adjournments of such meeting. If the proxy
is executed and returned, it will be voted at the meeting in accordance with any
instructions, and if no specification is made, the proxy will be voted for the
proposals set forth in the accompanying notice of the annual meeting of
shareholders. Shareholders who execute proxies may revoke them at any time
before they are voted, either by writing to the Company at the address shown
above or in person at the time of the meeting. Additionally, any later dated
proxy will revoke a previous proxy from the same shareholder. This proxy
statement was posted on the Company's website on July 12, 2013.

There is one class of capital stock outstanding. Provided a quorum
consisting of one-third of the shares entitled to vote is present at the
meeting, the affirmative vote of a majority of the shares of common stock voting
in person or represented by proxy is required to elect directors and to adopt
the other proposals to come before the meeting. Cumulative voting in the
election of directors is not permitted.

Shares of the Company's common stock represented by properly executed
proxies that reflect abstentions or "broker non-votes" will be counted as
present for purposes of determining the presence of a quorum at the annual
meeting. "Broker non-votes" represent shares held by brokerage firms in
"street-name" with respect to which the broker has not received instructions
from the customer or otherwise does not have discretionary voting authority.
Abstentions and broker non-votes will not be counted as having voted against the
proposals to be considered at the meeting.

PRINCIPAL SHAREHOLDERS

The following table lists, as of July 12, 2013, the shareholdings of (i)
each person owning beneficially 5% or more of the Company's common stock (ii)
each officer of the Company, (iii) each person nominated to be a director, and
(iv) all officers and nominees to the Board of Directors as a group. Unless
otherwise indicated, each owner has sole voting and investment powers over his
shares of common stock.

Name and Address Number of Shares (1) Percent of Class
---------------- -------------------- ----------------

Daniel B. O'Brien 4,521,900 34.3%
2614 Queenswood Dr.
Victoria, BC V8N 1X5

Dr. Robert N. O'Brien 1,795,000 13.6%
2614 Queenswood Dr.
Victoria, BC
Canada V8N 1X5

John Bientjes 35,000 0.3%
#1-230 West 13th Street,
North Vancouver, B.C.
Canada V7M 1N7

Dale Friend 20,000 0.2%
3009 E. Kent Ave.
Vancouver, BC
Canada V5S 4P6

Robert Helina 10,000 0.1%
Suite 262 505 - 8840 210th St.
Langley, BC
Canada V1M 2Y2

Dr. Thomas Fyles 5,000 --
Box 3065
Victoria, BC
Canada V8W 3V6

All Officers and Directors 6,386,900 48.5%
as a group (6 persons)

(1) Includes shares which may be acquired on the exercise of the stock options
listed below, all of which were exercisable as of July 12, 2013.

Shares Issuable
Upon the Exercise Exercise
Name of Options Price Expiration Date
---- ----------------- -------- ---------------

Dr. Robert 20,000 $1.50 January 1, 2016
O'Brien

John Bientjes 5,000 $2.25 January 1, 2014
5,000 $1.50 December 31, 2014
5,000 $1.50 January 1, 2016
5,000 $2.22 January 1, 2017

Dale Friend 5,000 $2.25 January 1, 2014
5,000 $1.50 December 31, 2014
5,000 $1.50 January 1, 2016
5,000 $2.22 January 1, 2017

Robert Helina 5,000 $2.45 September 22, 2016
5,000 $2.22 January 1, 2017

Dr. Thomas Fyles 5,000 2.00 August 8, 2017

ELECTION OF DIRECTORS

Unless the proxy contains contrary instructions, it is intended that the
proxies will be voted for the election of the persons listed below to serve as
members of the board of directors until the next annual meeting of shareholders
and until their successors shall be elected and shall qualify.

All nominees to the Board of Directors have consented to stand for
re-election. In case any nominee shall be unable or shall fail to act as a
director by virtue of an unexpected occurrence, the proxies may be voted for
such other person or persons as shall be determined by the persons acting under
the proxies in their discretion.

Daniel O'Brien, Dr. Robert O'Brien, John Bientjes and Dale Friend have
served as directors for a significant period of time and each of those
directors' long-standing experience with the Company benefits both the Company
and its shareholders. Dale Friend has accounting experience which benefits both
the Company and its shareholders. Robert Helina is qualified to act as a
director due to his longstanding financial experience. Dr. Fyles is qualified to
act as a director due to his experience in chemistry.

Information concerning the nominees to the Company's Board of Directors
follows:

Name Age Position
---- --- --------

Daniel B. O'Brien 57 President, Director
Dr. Robert N. O'Brien 91 Director
John H. Bientjes 60 Director
Dale Friend 58 Director
Robert Helina 47 Director
Thomas Fyles 61 Nominee to Board of
Directors
6

Directors are elected annually and hold office until the next annual
meeting of our stockholders and until their successors are elected and
qualified. All executive offices are chosen by the board of directors and serve
at the board's discretion.

Daniel B. O'Brien has served as the Company's President and Chief Executive
Officer, as well as a director of the Company since June 1998. He has been
involved in the swimming pool industry since 1990, when he founded the Company's
subsidiary, Flexible Solutions Ltd. From 1990 to 1998 Mr. O'Brien was also a
teacher at Brentwood College where he was in charge of outdoor education.

Dr. Robert N. O'Brien has been a director of the Company since June 1998.
Dr. O'Brien was a Professor of Chemistry at the University of Victoria from 1968
until 1986 at which time he was given the designation of Professor Emeritus. He
held various academic positions since 1957 at the University of Alberta, the
University of California at Berkley, and the University of Victoria. While
teaching, Dr. O'Brien acted as a consultant and served on the British Columbia
Research Council from 1968 to 1990. In 1987, Dr. O'Brien founded the Vancouver
Island Advanced Technology and Research Association. Dr. O'Brien received his
Bachelor of Applied Science in Chemical Engineering from the University of
British Columbia in 1951; his Masters of Applied Science in Metallurgical
Engineering from the University of British Columbia in 1952; his Ph.D. in
Metallurgy from the University of Manchester in 1955; and was a Post Doctoral
Fellow in Pure Chemistry at the University of Ottawa from 1955 through 1957. Dr.
O'Brien is the father of Daniel B. O'Brien.

John H. Bientjes has been a director of the Company since February 2000.
Since 1984, Mr. Bientjes has served as the manager of the Commercial Aquatic
Supplies Division of D.B. Perks & Associates, Ltd., located in Vancouver,
British Columbia, a company that markets supplies and equipment to commercial
swimming pools which are primarily owned by municipalities. Mr. Bientjes
graduated in 1976 from Simon Fraser University in Vancouver, British Columbia
with a Bachelor of Arts Degree in Economics and Commerce.

Dale Friend has been a director since December 2002. She has a diversified
background in the area of accounting and her experience has been primarily in
business, offering a wide range of accounting knowledge. Ms. Friend has worked
for a number of companies in their accounting departments, including Telus,
Novas Capital Corp. and DB Perks & Associates. She is currently working as
contract accountant for Delcor Holdings which is a privately held investment
company.

Robert T. Helina has been a director since October 2011. Mr. Helina has
been involved in the business financial services industry for over 20 years
which has given him extensive knowledge in business economics and finance. He
currently serves as the Executive Chairman on the Board of Directors for
SunCentro Corporation, providing corporate governance and guidance. Mr. Helina
is also the CFO and director of Metron Captial Corp., which is a publically
traded company. Mr. Helina holds a Bachelor of Arts degree from Trinity Western
University.

Thomas M. Fyles has been a director of the Company since August 2012. Since
1979 Dr. Fyles has been a chemistry professor at the University of Victoria
(Assistant Professor 1979-1984/Associate Professor 1984-1992/and Professor with

Tenure since 1992) Dr. Fyles received his Bachelor of Science degree (with
honors) from the University of Victoria in 1974 and his Ph.D. in chemistry from
York University in 1977. Dr. Fyles was a postdoctoral fellow with Prof. J.M.
Lehn, Institut Le Bel, Universite Louis Pasteur, Strasbourg, France, between
September 1977 and July 1979.

Daniel B. O'Brien devotes substantially all of his time to the Company's
business.

The Company's Board of Directors met on four occasions during the year
ended December 31, 2012. All of the Directors, attended each of these meetings
either in person, by telephone conference call or email.

The Company's Board of Directors does not have a "leadership structure", as
such, since each director is entitled to introduce resolutions to be considered
by the Board and each director is entitled to one vote on any resolution
considered by the Board. The Company's Chief Executive Officer is not the
Chairman of the Company's Board of Directors.

The Company's Board of Directors has the ultimate responsibility to
evaluate and respond to risks facing the Company. The Company's Board of
Directors fulfills its obligations in this regard by meeting on a regular basis
and communicating, when necessary, with the Company's officers.

John Bientjes, Dale Friend, Robert Helina and Dr. Thomas Fyles are
independent directors as that term is defined in section 803 of the listing
standards of the NYSE MKT.

For purposes of electing directors at its annual meeting the Company does
not have a nominating committee or a committee performing similar functions. The
Company's board of directors does not believe a nominating committee is
necessary since the Company's board of directors is small and the board of
directors as a whole performs this function. The current nominees to the Board
of Directors were selected by a majority vote of the Company's independent
directors.

The Company does not have any policy regarding the consideration of
director candidates recommended by shareholders since a shareholder has never
recommended a nominee to the board of directors. However, the Company's board of
directors will consider candidates recommended by shareholders. To submit a
candidate for the board of directors the shareholder should send the name,
address and telephone number of the candidate, together with any relevant
background or biographical information, to the Company's Chief Executive
Officer, at the address shown on the cover page of this proxy statement. The
board has not established any specific qualifications or skills a nominee must
meet to serve as a director. Although the board does not have any process for
identifying and evaluating director nominees, the board does not believe there
would be any differences in the manner in which the board evaluates nominees
submitted by shareholders as opposed to nominees submitted by any other person.
There have been no material changes to the procedures by which security holders
may recommend nominees to the Company's board of directors during the past three
years.

The Company does not have a policy with regard to board member's attendance
at annual meetings. All board members, with the exception of Thomas Fyles who
was not then a director at the time, attended the last annual shareholder's
meeting held on August 23, 2012.

Holders of the Company's common stock can send written communications to
the Company's entire board of directors, or to one or more board members, by
addressing the communication to "the Board of Directors" or to one or more
directors, specifying the director or directors by name, and sending the
communication to the Company's offices in Victoria, British Columbia.
Communications addressed to the Board of Directors as whole will be delivered to
each board member. Communications addressed to a specific director (or
directors) will be delivered to the director (or directors) specified.

Security holder communications not sent to the board of directors as a
whole or to specified board members are not relayed to board members.

The Company has adopted a Code of Ethics that applies to the its Principal
Financial and Accounting Officer, as well as the other company employees. The
Code of Ethics is available at the Company's website at
www.flexiblesolutions.com.

If a violation of the code of ethics act is discovered or suspected, an
officer of the Company must (anonymously, if desired) send a detailed note, with
relevant documents, to the Company's Audit Committee, c/o John Bientjes, #1-230
West 13th St., North Vancouver, B.C., Canada V7M 1N7.

Executive Compensation

The following table shows in summary form the compensation earned by (i)
the Company's Principal Executive and Financial Officer and (ii) by each other
executive officer of the Company who earned in excess of $100,000 during the
fiscal years ended December 31, 2012 and 2011:

All
Other
Restric- Annual
ted Stock Options Compen-
Name and Princi- Fiscal Salary Bonus Awards Awards sation
pal Position Year (1) (2) (3) (4) (5) Total
---------------- ----- ----------- ---------- ---------- ---------- --------- -----

Daniel B. O'Brien 2012 $ 612,000 -- -- $ 17,742 -- $629,926
President, Principal 2011 $ 174,505 -- -- $ 29,799 -- $204,304
Executive and
Financial Officer

(1) The dollar value of base salary (cash and non-cash) earned.

(2) The dollar value of bonus (cash and non-cash) earned.

(3) During the periods covered by the table the fair value of stock issued for
services computed in accordance with ASC 718 on the date of grant.

(4) During the periods covered by the table the fair value of options granted
computed in accordance with ASC 718 on the date of grant. In June 2012, at
the request of Mr. O'Brien, all options held by Mr. O'Brien were cancelled.

(5) All other compensation received that could not properly be reported in any
other column of the table.

Stock Option Program

The Company's Stock Option Program involves the issuance of options, from
time to time, to the Company's employees, directors, officers, consultants and
advisors. Options are granted by means of individual option agreements. Each
option agreement specifies the shares issuable upon the exercise of the option,
the exercise price, the expiration date and other terms and conditions of the
option.

If the option holder is an employee, and if he or she ceases to be employed
by the Company, the option holder may, during the 30-day period following
termination of employment, exercise the option to the extent the option was
exercisable on the date of termination. In the case of death or disability, the
option holder (or his or her administrator) has twelve months from the date of
death or disability to exercise the option to the extent the option was
exercisable on the date of death or disability.

The options are subject to adjustment by reason of a recapitalization,
reclassification, stock split, combination of shares, dividend or other
distribution payable in capital stock. Upon a merger, liquidation, dissolution
or other consolidation, the Company will provide each option holder with
one-months' prior written notice informing the option holder that he or she may
exercise the option in full (to the extent it has not been previously exercised)
within the one-month period. Following the expiration of the one month period,
the options will terminate.

The options may not be transferred, assigned, pledged or hypothecated in
any way (except by will or the laws of descent) and are not subject to
execution, attachment or similar process.

All of the options granted have terms of between one and five years after
the date of grant and reflect exercise prices equal to the fair market value of
a share of the Company's common stock, as determined by the Company's board of
directors on the date of grant. All of the options contain vesting provisions
pursuant to which the options are fully exercisable within a fixed number of
months after the date of grant.

All option grants made to the Company's officers and directors during a
fiscal year are submitted for shareholder approval at the next annual
shareholder meeting. To date, the Company's shareholders have approved all of
the grants.

The following table shows the weighted average exercise price of the
outstanding options granted pursuant to the Company's Stock Option Program as of
December 31, 2012:

Number of
Number of
Securities
Remaining
Number of Available for
Securities to Future Issuance
be Issued Upon Weighted-Average Under
Exercise of Exercise Price of Equity Compensation
Outstanding Outstanding Plans (Excluding
Options, Options, Securities
Warrants and Warrants and Reflected
Plan Category Rights Rights In Column (a))
--------------------------- -------------- --------------- ------------------
(a) (b) (c)

Stock Option Program 999,000 $1.96 Not Applicable
------- -----
Total 999,000 $1.96
======= =====

As of July 12, 2013 options to purchase 1,114,000 shares of the Company's
common stock were outstanding under the Stock Option Program. The exercise price
of these options varies between $1.21 and $2.45 per share. The options expire at
various dates between January 1, 2014 and December 31, 2017.

Director Compensation

The Company reimburses directors for any expenses incurred in attending
board meetings. The Company also compensates directors $2,000 annually and at
times grants directors options to purchase shares of common stock each year that
they serve.

The Company's directors received the following compensation during the year
ended December 31, 2012:

Name Paid in Cash Stock Awards (1) Option Awards (2)
---- ------------ ---------------- -----------------

Robert N. O'Brien -- -- --
John H. Bientjes $2,000 -- $3,582
Dale Friend $2,000 -- $3,582
Robert Helina $2,000 -- $3,582
Dr. Thomas Fyles -- -- $1,878

(1) The fair value of stock issued for services computed on the date of grant.

(2) The fair value of options granted computed in accordance with on the date
of grant.

The terms of outstanding options held by the Company's directors as of July
12, 2013 are shown below.

Name Option Price No. of Options Expiration Date
---- ------------ -------------- ---------------

Dr. Robert O'Brien $1.50 20,000 January 1, 2016
John H. Bientjes $3.60 5,000 January 31, 2013
John H. Bientjes $2.25 5,000 January 1, 2014
John H. Bientjes $1.50 5,000 December 31, 2014
John H. Bientjes $1.50 5,000 January 1, 2016
John H. Bientjes $2.22 5,000 January 1, 2017
Dale Friend $3.60 5,000 January 31, 2013
Dale Friend $2.25 5,000 January 1, 2014
Dale Friend $1.50 5,000 December 31, 2014
Dale Friend $1.50 5,000 January 1, 2016
Dale Friend $2.22 5,000 January 1, 2017
Robert Helina $2.45 5,000 September 22, 2016
Robert Helina $2.22 5,000 January 1, 2017
Dr. Thomas Fyles $2.00 5,000 August 8, 2017

Daniel B. O'Brien is not compensated for serving as a director.

Compensation Committee

The Company's Compensation Committee consists of John Bientjes, Dale Friend
and Robert Helina, all of whom are independent as that term is defined in
Section 803 of the listing standards of the NYSE MKT.

The Compensation Committee is empowered to review and approve the annual
compensation and compensation procedures for the Company's officers and
determines the total compensation level for the Company's Chief Executive
Officer. The total proposed compensation of the Company's Chief Executive
Officer is formulated and evaluated by its Chief Executive Officer and submitted
to the Company's Compensation Committee for consideration.

During the year ended December 31, 2012 the Compensation Committee met
once. All members of the Compensation Committee attended this meeting.

During the year ended December 31, 2012, Daniel B. O'Brien, the Company's
only executive officer, did not participate in deliberations of the Company's
Compensation Committee concerning executive officer compensation.

During the year ended December 31, 2012, no director of the Company was
also an executive officer of another entity, which had an executive officer of
the Company serving as a director of such entity or as a member of the
Compensation Committee of such entity.

The following is the report of the Compensation Committee:

The key components of the Company's executive compensation program include
annual base salaries and long-term incentive compensation consisting of stock
options. It is the Company's policy to target compensation (i.e., base salary,
stock option grants and other benefits) at approximately the median of
comparable companies in the industries in which the Company competes.
Accordingly, data on compensation practices followed by other companies in the
industries in which the Company competes is considered.

The Company's long-term incentive program consists exclusively of periodic
grants of stock options with an exercise price equal to the fair market value of
the Company's common stock on the date of grant. To encourage retention, the
ability to exercise options granted under the program may be subject to vesting
restrictions. Decisions made regarding the timing and size of option grants take
into account the performance of both the Company and the employee, "competitive
market" practices, and the size of the option grants made in prior years. The
weighting of these factors varies and is subjective. Current option holdings are
not considered when granting options.

Audit Committee

The Company's Audit Committee consists of John Bientjes, Dale Friend and
Robert Helina, all of whom and have strong financial backgrounds. The purpose of
the Audit Committee is to review and approve the selection of the Company's
auditors and review the Company's financial statements with the Company's
independent registered public accounting firm. The Audit Committee also serves
as an independent and objective party to monitor the Company's financial
reporting process and internal control systems. The Audit Committee meets
periodically with management and the Company's independent auditors. Dale Friend
is the audit committee's financial expert.

During the fiscal year ended December 31, 2012, the Audit Committee met
four times. All members of the Audit Committee attended these meetings.

The following is the report of the Audit Committee:

(1) The Audit Committee reviewed and discussed the Company's audited
financial statements for the year ended December 31, 2012 with the
Company's management.

(2) The Audit Committee discussed with the Company's independent
registered public accounting firm the matters required to be discussed
by Statement on Accounting Standards (SAS) No. 61 "Communications with
Audit Committee" as amended by SASs 89 and 90.

(3) The Audit Committee has received the written disclosures and the
letter from the Company's independent registered public accounting
firm required by PCAOB (Public Company Accounting Oversight Board)
standards, and had discussed with the Company's independent registered
public accounting firm the independent registered public accounting
firm's independence; and

(4) Based on the review and discussions referred to above, the Audit
Committee recommended to the Board of Directors that the audited
financial statements be included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2012 for filing with the
Securities and Exchange Commission.

(5) During the year ended December 31, 2012 the Company paid Meyers Norris
Penny LLP, the Company's independent registered public accounting
firm, audit and audit related fees of $72,022 for professional
services rendered for the audit of the Company's annual financial
statements and the reviews of the financial statements included in the
Company's 10-Q reports for the fiscal year and all regulatory filings.
The Audit Committee is of the opinion that these fees are consistent
with maintaining its independence from the Company.

The foregoing report has been approved by the members of the Audit
Committee:

John Bientjes
Dale Friend
Robert Helina

The Company's Board of Directors has adopted a written charter for the
Audit Committee, a copy of which is available on the Company's website:
www.flexiblesolutions.com.

PROPOSAL TO RATIFY STOCK OPTION GRANT TO JOHN BIENTJES

Shareholders are being requested to vote on the ratification of an option
grant to John Bientjes, a director of the Company. The purpose of the option
grant is to furnish additional compensation and incentives to Mr. Bientjes.

If ratified, the option would allow Mr. Bientjes to purchase 5,000 shares
of the Company's common stock at an exercise price of $1.21 at any time after
December 31, 2013 and on or before December 31, 2017.

PROPOSAL TO RATIFY STOCK OPTION GRANT TO DALE FRIEND

Shareholders are being requested to vote on the ratification of an option
grant to Dale Friend, a director of the Company. The purpose of the option grant
is to furnish additional compensation and incentives to Ms. Friend.

If ratified, the option would allow Ms. Friend to purchase 5,000 shares of
the Company's common stock at an exercise price of $1.21 at any time after
December 31, 2013 and on or before December 31, 2017.

PROPOSAL TO RATIFY STOCK OPTION GRANT TO ROBERT HELINA

Shareholders are being requested to vote on the ratification of option
grants to Robert Helina, a director of the Company. The purpose of the option
grants is to furnish additional compensation and incentives to Mr. Helina.

If ratified, the first option would allow Mr. Helina to purchase 5,000
shares of the Company's common stock at an exercise price of $1.21 at any time
after December 31, 2013 and on or before December 31, 2017.

PROPOSAL TO RATIFY STOCK OPTION GRANT TO THOMAS FYLES

Shareholders are being requested to vote on the ratification of option
grants to Thomas Fyles, a director of the Company. The purpose of the option
grants is to furnish additional compensation and incentives to Dr. Fyles.

If ratified, the first option would allow Dr. Fyles to purchase 5,000
shares of the Company's common stock at an exercise price of $1.21 at any time
after December 31, 2013 and on or before December 31, 2017.

ADVISORY VOTE ON EXECUTIVE COMPENSATION

The recently enacted Dodd-Frank Wall Street Reform and Consumer Protection
Act of 2010, or the Dodd-Frank Act, enables the Company's shareholders to vote
to approve, on a nonbinding advisory basis, the compensation of the Company's
executive officers.

Accordingly, the Company will ask shareholders to vote for the following
resolution at the annual meeting:

"RESOLVED, that the Company's shareholders approve, on a nonbinding
advisory basis, the compensation of the Company's executive officers, as
disclosed in the Company's Proxy Statement for the 2012 Annual Meeting of
Shareholders pursuant to the compensation disclosure rules of the
Securities and Exchange Commission, including the Summary Compensation
Table and the other related tables and narrative disclosure in the
Company's proxy statement."

To the extent there is any significant vote against the named executive
officer compensation as disclosed in this proxy statement, the Company's Board
of Directors and its Compensation Committee will consider shareholders' concerns
and the Compensation Committee will evaluate whether any actions are necessary
to address those concerns.

The Board of Directors recommends that the shareholders approve on a
nonbinding advisory basis the aforementioned resolution approving the
compensation of the Company's executive officers set forth in this proxy
statement.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors has selected Meyers, Norris, Penny, LLP, an
independent registered public accounting firm, to audit the books and records of
the Company for the fiscal year ending December 31, 2013. Meyers, Norris, Penny
served as the Company's independent registered public accounting firm for the
fiscal years ended December 31, 2012 and 2011. A representative of Meyers,
Norris, Penny, is expected to be present at the shareholders' meeting.

The following table shows the aggregate fees billed to the Company during
the years ended December 31, 2012 and 2011 by Meyers Norris Penny LLP:

Year Ended December 31,
2012 2011
---- ----

Audit Fees $72,022 $72,185
Audit-Related Fees -- --
Tax Fees $17,005 $ 22,394
All Other Fees -- --

Audit fees represent amounts billed for professional services rendered for
the audit of the Company's annual financial statements and the reviews of the
financial statements included in the Company's 10-Q reports for the fiscal year
and all regulatory filings. Audit-related fees represent amounts billed for
reviewing amendments to the Company's 10-K and 10-Q reports. Before Meyers
Norris Penny was engaged by the Company to render audit or non-audit services,
the engagement was approved by the Company's audit committee. The Company's
Board of Directors is of the opinion that the audit fees charged by Meyers
Norris Penny are consistent with that firm maintaining its independence from the
Company.

AVAILABILITY OF ANNUAL REPORT ON FORM 10-K

The Company's Annual Report on Form 10-K for the year ending December 31,
2012 will be sent to any shareholder of the Company upon request. Requests for a
copy of this report should be addressed to the Company's Secretary at the
address provided on the first page of this proxy statement.

SHAREHOLDER PROPOSALS

Any shareholder proposal which may properly be included in the proxy
solicitation material for the annual meeting of shareholders following the
Company's year ending December 31, 2013 must be received by the Company's
Secretary no later than March 31, 2014.

GENERAL

The cost of preparing, printing and mailing the enclosed proxy,
accompanying notice and proxy statement, and all other costs in connection with
solicitation of proxies will be paid by the Company including any additional
solicitation made by letter, telephone or email. Failure of a quorum to be
present at the meeting will necessitate adjournment and will subject the Company
to additional expense. The Company's annual report, including financial
statements for the 2012 fiscal year, is available at the Company's website:
www.flexiblesolutions.com.

The Company's Board of Directors does not intend to present and does not
have reason to believe that others will present any other items of business at
the annual meeting. However, if other matters are properly presented to the
meeting for a vote, the proxies will be voted upon such matters in accordance
with the judgment of the persons acting under the proxies.

Please complete, sign and return the attached proxy promptly.

PROXY CARD
FLEXIBLE SOLUTIONS INTERNATIONAL, INC.
This Proxy is solicited by the Company's Board of Directors

The undersigned stockholder of Flexible Solutions International, Inc.
acknowledges receipt of the Notice of the Annual Meeting of Stockholders to be
held August 29, 2013, at 6:00 p.m. local time, at the Company's offices located
at 615 Discovery St, Victoria BC, V8T 5G4 and hereby appoints Daniel O'Brien
with the power of substitution, as Attorney and Proxy to vote all the shares of
the undersigned at said annual meeting of stockholders and at all adjournments
thereof, hereby ratifying and confirming all that said Attorney and Proxy may do
or cause to be done by virtue hereof. The above named Attorney and Proxy is
instructed to vote all of the undersigned's shares as follows:

(1) To elect the persons who shall constitute the Company's Board of Directors
for the ensuing year.

[ ] FOR all nominees listed below (except as marked to the contrary below)

[ ] WITHHOLD AUTHORITY to vote for all nominees listed below

(INSTRUCTION: TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE, STRIKE A
LINE THROUGH THE NOMINEE'S NAME IN THE LIST BELOW)

Nominees: Daniel B. O'Brien Dr. Robert N. O'Brien John H. Bientjes
Dale Friend Robert Helina Thomas Fyles

(2) To ratify an option granted to John Bientjes which allows Mr. Bientjes to
purchase 5,000 shares of the Company's common stock at a price of $1.21 per
share at any time after December 31, 2013 and on or before December 31,
2017.